<DOC>
	<DOCNO>NCT02043080</DOCNO>
	<brief_summary>This study evaluate Xpert MTB/RIF first-line TB diagnostic test HIV-infected adult paediatric patient mean obtain faster , accurate TB diagnosis .</brief_summary>
	<brief_title>Optimizing Clinical Outcomes HIV-Infected Adults &amp; Children</brief_title>
	<detailed_description>This study evaluate Xpert Mycobacterium Tuberculosis/Rifampicin ( MTB/RIF ) first-line Tuberculosis ( TB ) diagnostic test Human Immunodeficiency Virus ( HIV ) -infected adult paediatric patient peri-urban setting determine impact accurate case detection treatment initiation setting . In addition , Determine TB-Lipoarabinomannan ( LAM ) Ag速 use model add diagnostic value use alone combination Xpert MTB/RIF , within TB diagnostic algorithm HIV infect patient Zambia . A quasi-experimental `` before-after '' study design use two similar peri-urban district hospital . Each site initially implement Standard Care ( SOC ) phase , prospective cohort HIV-infected adult paediatric TB suspect screen TB accord current standard care Zambian HIV care clinic . This follow 4-week `` intervention wash-out '' period allow completion diagnostic work-up patient recruit last month SOC phase . The second phase ( Xpert MTB/RIF phase ) start immediately follow `` intervention wash-out '' period . In phase , second cohort HIV-infected adult paediatric TB suspect screen TB use Xpert MTB/RIF algorithm . Each phase last approximately 6 month , target sample size adult reach . Mycobacterial culture perform study confirm TB diagnosis determine whether appropriate treatment give . `` Appropriate treatment '' mean patient initiate ATT within 4 week screen initiation culture-positive patient correct diagnosis TB culture-negative patient . Culture result release CIDRZ Lab patient care soon result available . During study phase participant ask submit urine sample test Determine TB-LAM Ag速 assay . Urine specimen collect study site procedure carry CIDRZ Central Laboratory Lusaka use standard laboratory protocol quality assurance procedure . Since Determine TB-LAM Ag速 yet endorse World Health Organization ( WHO ) approve Zambian Ministry Health TB diagnosis , result Determine TB-LAM Ag速 assay use patient care .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<criteria>Aged 15 year ( `` Adult '' ) , less 15 year old ( `` Child '' ) ; HIVinfected enrol HIV care Chongwe Kafue District Hospitals Intends continue receive care district hospital least 6 month . TB suspect accord Zambian National Guidelines [ 31 ] ; Willing provide sign informed consent ( parental consent , participant 18 ) ; Willing ( parent guardian willing ) provide locator information allow contact phone home visit Diagnosed TB within last 6 month take TB treatment last 3 month Enrolled another study might interfere study objective ( ex . TBHAART )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Tuberculosis</keyword>
	<keyword>HIV</keyword>
	<keyword>Xpert MTB/RIF</keyword>
	<keyword>Determine TB-LAM</keyword>
	<keyword>UNC</keyword>
	<keyword>Zambia</keyword>
	<keyword>Cost Effectiveness Analysis Curve</keyword>
	<keyword>Centre Infectious Disease Research Zambia</keyword>
</DOC>